Manning Paul B
Director · 8 filings · Latest: Sep 30, 2026
Candel Therapeutics, Inc.
Liquidia Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LQDA | Manning Paul B | Director | Jun 4, 2026 | Sale | $63.91 | 200,000 | $12.8M | 798,335 | |
LQDA | Paul B Manning | — | Jun 4, 2026 | Proposed Sale | $55.69 | 200,000 | $11.1M | — | |
CADL | Manning Paul B | Director | Feb 23, 2026 | Purchase | $5.45 | 550,458 | $3.0M | 2,763,527 | |
LQDA | Manning Paul B | — | Aug 29, 2025 | Proposed Sale | $27.60 | 947,328 | $26.1M | — | |
LQDA | Manning Paul B | — | Aug 28, 2025 | Proposed Sale | $27.94 | 154,337 | $4.3M | — |